The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia

European Journal of Haematology

Volumn 83, Issue 4, 2009, Pages 292-301

  Xubo, Gong ^a   Xingguo, Lu ^a   Xianguo, Wu ^a   Rongzhen, Xu ^a   Xibin, Xiao ^a   Lin, Wang ^a   Lei, Zhu ^a   Xiaohong, Zhang ^a   Genbo, Xu ^a   Xiaoying, Zhao ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Atypical chronic myeloid leukemia; Bone marrow aspirate; Bone marrow trephine biopsy; Chronic granulocytic leukemia; Chronic myelomonocytic leukemia; Peripheral blood

Indexed keywords

RETICULIN;

ADULT; AGED; ANEMIA; ARTICLE; ATYPICAL CHRONIC MYELOID LEUKEMIA; BASOPHIL; BLAST CELL; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER PATIENT; CELL COUNT; CHRONIC GRANULOCYTIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSERYTHROPOIESIS; EOSINOPHIL; FEMALE; GRANULOCYTE; GRANULOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LEUKOCYTOSIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTOSIS; MYELOFIBROSIS; PARAMETER; PRIORITY JOURNAL; THROMBOCYTOPENIA; TISSUE SECTION;

AGED; AGED, 80 AND OVER; BIOPSY; BLOOD CELLS; BONE MARROW; BONE MARROW EXAMINATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED;

EID: 70349161101     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01283.x     Document Type: Article

References (22)

1. Galton D. Hematological differences between chronic granulocytic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia. Leuk Lymphoma 1992 7 : 343 350.
2. Vardiman JW, Pierre R, Bain B, Bennett JM, Imbert M, Brunning RD, Flandrin G. Myelodysplastic/myeloproliferative diseases. In : Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon,France : IARC Press, 2001 : 47 59.
3. Oscier DG. Atypical chronic myeloid leukaemia, a distinct clinical entitity related to the myelodysplastic syndrome? Br J Haematol 1996 92 : 582 586.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, Sultan C, Cox C. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid and chronic myelomonocytic leukemias. Proposals by the French-American-British Cooperatives Leukemia group. Br J Haematol 1994 87 : 746 754.
5. Hernández JM, del Cañizo MC, Cuneo A, García JL, Gutiérrez NC, González M, Castoldi G, San Miguel JF. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000 11 : 441 444.
6. Preisler H, Barcos M, Reese P, Priore RL, Pothier L. Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Leuk Res 1983 7 : 67 75.
7. Ngo NT, Lampert IA, Naresh KN. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia. Br J Haematol 2008 141 : 771 781.
8. Manoharan A, Horsley R, Pitney WR. The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 1979 43 : 185 190.
9. Schaumburg-Lever G. The alkaline phosphatase anti-alkaline phosphatase technique in dermatopathology. J Cutan Pathol 1987 14 : 6 9.
10. Shin M, Izumi S, Nakane PK. Multilayer peroxidase-labeled antibody method: comparison with labeled streptavidin-biotin method, avidin-biotin- peroxidase complex method, and peroxidase-antiperoxidase method. J Clin Lab Anal 1995 9 : 424 430.
11. Palmer CG, Blouin JL, Bull MJ. Cytogenetics and molecular analysis of a ring (21) in a patient with partial trisomy 21 and megakaryocytic leukemia. Am J Med Genet 1995 57 : 527 536.
12. Maillo A, Diaz P, Sayagues JM, Blanco A, Tabernero MD, Ciudad J. Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer 2001 92 : 377 385.
13. Orazi A, Germing U. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 2008 22 : 1308 1319.
14. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 100 : 2292 2302.
15. Malcovati L, Cazzola M. Myelodysplastic/myeloproliferative disorders. Haematologica 2008 93 : 4 6.
16. Schwaller J, Anastasiadou E, Cain D, et al. H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5; 10)(q33;q22). Blood 2001 97 : 3910 3918.
17. Fend F, Horn T, Koch I, Vela T, Orazi A. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm. Leuk Res 2008 32 : 1931 1935.
18. Neuwirtovä R, Mocikova K, Jelínek J, Musilova J, Havlicek F, Adamkov M. Mixed myelodysplastic and myeloproliferative syndromes. Leuk Res 1996 20 : 717 726.
19. Breccia M, Biondo F, Latagliata R, Carmosino I, Mandelli F, Alimena G. Identification of risk factors in atypical chronic myeloid. Leukemia 2006 91 : 1566 1568.
20. Maschek H, Gutzmer R, Choritz H, Georgii A. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients. Eur J Haematol 1994 53 : 280 287.
21. Orazi A, Chiu R, Malley DP, Czader M, Allen SL, An C, Vance GH. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol 2006 19 : 1536 1545.
22. Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol 2008 30 : 349 364.